List of Excipients in API lidocaine hci
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing lidocaine hci
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| HF Acquisition Co LLC DBA HealthFirst | LIDOCAINE HCI | lidocaine hci | 51662-1364 | HYDROCHLORIC ACID | |
| HF Acquisition Co LLC DBA HealthFirst | LIDOCAINE HCI | lidocaine hci | 51662-1364 | SODIUM CHLORIDE | |
| HF Acquisition Co LLC DBA HealthFirst | LIDOCAINE HCI | lidocaine hci | 51662-1364 | SODIUM HYDROXIDE | |
| HF Acquisition Co LLC DBA HealthFirst | LIDOCAINE HCI AND DEXTROSE | lidocaine hci and dextrose | 51662-1302 | DEXTROSE MONOHYDRATE | |
| HF Acquisition Co LLC DBA HealthFirst | LIDOCAINE HCI AND DEXTROSE | lidocaine hci and dextrose | 51662-1302 | SODIUM HYDROXIDE | |
| HF Acquisition Co LLC DBA HealthFirst | LIDOCAINE HCI AND DEXTROSE | lidocaine hci and dextrose | 51662-1302 | WATER | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing lidocaine hci
Detailed excipient profiles for lidocaine hci
Excipient focus: ANHYDROUS CITRIC ACID
lidocaine hci drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC DBA HealthFirst | lidocaine hci | 51662-1232 |
| HF Acquisition Co LLC DBA HealthFirst | lidocaine hci | 51662-1419 |
| HF Acquisition Co LLC DBA HealthFirst | lidocaine hci and epinephrine | 51662-1395 |
| >Company | >Ingredient | >NDC |
lidocaine hci drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: CITRIC ACID MONOHYDRATE
lidocaine hci drug variants containing CITRIC ACID MONOHYDRATE
lidocaine hci drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: DEXTROSE MONOHYDRATE
lidocaine hci drug variants containing DEXTROSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC DBA HealthFirst | lidocaine hci and dextrose | 51662-1302 |
| >Company | >Ingredient | >NDC |
lidocaine hci drug variants not containing DEXTROSE MONOHYDRATE
Excipient focus: HYDROCHLORIC ACID
lidocaine hci drug variants containing HYDROCHLORIC ACID
lidocaine hci drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC DBA HealthFirst | lidocaine hci and dextrose | 51662-1302 |
| HF Acquisition Co LLC DBA HealthFirst | lidocaine hci and dextrose | 51662-1565 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
lidocaine hci drug variants containing METHYLPARABEN
lidocaine hci drug variants not containing METHYLPARABEN
Excipient focus: SODIUM CHLORIDE
lidocaine hci drug variants containing SODIUM CHLORIDE
lidocaine hci drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC DBA HealthFirst | lidocaine hci | 51662-1382 |
| HF Acquisition Co LLC DBA HealthFirst | lidocaine hci and dextrose | 51662-1302 |
| HF Acquisition Co LLC DBA HealthFirst | lidocaine hci and dextrose | 51662-1565 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
lidocaine hci drug variants containing SODIUM HYDROXIDE
lidocaine hci drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| HF Acquisition Co LLC DBA HealthFirst | lidocaine hci and dextrose | 51662-1565 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM METABISULFITE
lidocaine hci drug variants containing SODIUM METABISULFITE
lidocaine hci drug variants not containing SODIUM METABISULFITE
Excipient focus: WATER
lidocaine hci drug variants containing WATER
lidocaine hci drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
